The more your skin is exposed to the sun, the more you increase your chances of skin cancer. But did you know that even areas that aren’t exposed to the sun can also be affected? It’s true. While skin cancer is more likely to form in areas that see overexposure to the sun, well-covered areas like the palms and genital areas can also be impacted by skin cancer.
So, what exactly is skin cancer? It’s the abnormal growth of skin cells. According to the American Cancer Society, skin cancer is the most common cancer in the United States. Melanoma, the deadliest form of cancer, kills more than 10,000 Americans each year. That makes up 75 percent of cancer deaths in the country. While skin cancer is scary, there is good news. Most forms of skin cancer can be prevented and easily treated.
The global Skin Cancer Treatment Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2021-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the skin cancer treatment market include Merck & Co., Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd., Amgen Inc., GlaxoSmithKline plc, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Inc.
Presently, between 2 to 3 million non-melanoma skin cancers and 132,000, melanoma skin cancers occur globally each year.
A various unified approach, comprehensive, communitywide efforts to prevent skin cancer are being implemented, which amplifies market revenue.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
